Showing 1,421 - 1,440 results of 60,771 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 0.92s Refine Results
  1. 1421
  2. 1422
  3. 1423
  4. 1424
  5. 1425

    Flow chart. by Raphaele Houlbracq (20558509)

    Published 2025
    “…The difference in overall prevalence of OASI between 2010 (0.7%) and 2021 (1.0%) was not statistically significant after adjustment (aRR 1.24, 95% CI 0.91 to 1.68). By groups of classification, the prevalence of OASI increased significantly only in Group 2b [nulliparous term cephalic singleton with spatula delivery] from 2.6% (95% CI 1.2 to 5.6) in 2010 to 9.6% (95% CI 6.2 to 14.7) in 2021 (aRR 3.69, 95% CI 1.50 to 9.09), and did not differ statistically significantly in Group 2a [nulliparous term cephalic singleton with forceps delivery] from 3.2% (95% CI 1.8 to 5.7) in 2010 to 5.7% (95% CI 3.4 to 9.5) in 2021 (aRR 1.78, 95% CI 0.81 to 3.90).…”
  6. 1426

    Data used to generate Fig 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…However, this irradiation dose could be reduced to 5 Gy to sterilize both males and females infected with <i>Wolbachia</i>. …”
  7. 1427

    Data used to generate Table 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…However, this irradiation dose could be reduced to 5 Gy to sterilize both males and females infected with <i>Wolbachia</i>. …”
  8. 1428
  9. 1429

    DataSheet_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.pdf by Yun Ji (464484)

    Published 2022
    “…However, the continuous virus evolution requires diverse mAb options to combat variants. Here we describe two fully human mAbs, amubarvimab (BRII-196) and romlusevimab (BRII-198) that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein and effectively neutralize SARS-CoV-2 variants. …”
  10. 1430

    DPT3 Stat EDHS for five surveys. by Hailu Fekadu (17797638)

    Published 2024
    “…Regarding educational status, inequality (RII) show decreasing pattern from 7.2% (2000) to 1.5% in(2019). …”
  11. 1431
  12. 1432

    Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma by Harry A. Quigley (695817)

    Published 2015
    “…</p><p>Methods</p><p>We produced IOP increase in CD1 mice and performed unilateral optic nerve crush. …”
  13. 1433
  14. 1434
  15. 1435
  16. 1436
  17. 1437
  18. 1438

    Design of the D-trial. by Torsten Schober (20485754)

    Published 2024
    “…Empirical models for the relationships between the investigated plant traits and PD/DVP were created using linear regression analysis preceded by a lack-of-fit test. An increase in PD led to a linear decrease in inflorescence yield per plant (<i>p</i> = 0.02), whereas a positive linear relationship was found for inflorescence yield (<i>p</i> = 0.0001) and CBD yield (<i>p</i> = 0.0002) per m<sup>2</sup>. …”
  19. 1439

    Estimated mean values for light interception. by Torsten Schober (20485754)

    Published 2024
    “…Empirical models for the relationships between the investigated plant traits and PD/DVP were created using linear regression analysis preceded by a lack-of-fit test. An increase in PD led to a linear decrease in inflorescence yield per plant (<i>p</i> = 0.02), whereas a positive linear relationship was found for inflorescence yield (<i>p</i> = 0.0001) and CBD yield (<i>p</i> = 0.0002) per m<sup>2</sup>. …”
  20. 1440

    Raw data D-trial. by Torsten Schober (20485754)

    Published 2024
    “…Empirical models for the relationships between the investigated plant traits and PD/DVP were created using linear regression analysis preceded by a lack-of-fit test. An increase in PD led to a linear decrease in inflorescence yield per plant (<i>p</i> = 0.02), whereas a positive linear relationship was found for inflorescence yield (<i>p</i> = 0.0001) and CBD yield (<i>p</i> = 0.0002) per m<sup>2</sup>. …”